BRPI0813404A2 - Derivados de uréia e carbamato como inibidores de transcriptase reversa de não-nucleosídeo - Google Patents

Derivados de uréia e carbamato como inibidores de transcriptase reversa de não-nucleosídeo

Info

Publication number
BRPI0813404A2
BRPI0813404A2 BRPI0813404-9A2A BRPI0813404A BRPI0813404A2 BR PI0813404 A2 BRPI0813404 A2 BR PI0813404A2 BR PI0813404 A BRPI0813404 A BR PI0813404A BR PI0813404 A2 BRPI0813404 A2 BR PI0813404A2
Authority
BR
Brazil
Prior art keywords
urea
reverse transcriptase
transcriptase inhibitors
nucleoside reverse
carbamate derivatives
Prior art date
Application number
BRPI0813404-9A2A
Other languages
English (en)
Inventor
Todd Richard Elworthy
Joan Heather Hogg
Joshua Kennedy-Smith
Counde O'yang
Mark Smith
Zachary Kevin Sweeney
Jeffrey Wu
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI0813404A2 publication Critical patent/BRPI0813404A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BRPI0813404-9A2A 2007-06-22 2008-06-12 Derivados de uréia e carbamato como inibidores de transcriptase reversa de não-nucleosídeo BRPI0813404A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93695607P 2007-06-22 2007-06-22
PCT/EP2008/057391 WO2009000663A1 (en) 2007-06-22 2008-06-12 Urea and carbamate derivatives as non-nucleoside reverse transcriptase inhibitors

Publications (1)

Publication Number Publication Date
BRPI0813404A2 true BRPI0813404A2 (pt) 2014-12-30

Family

ID=39811644

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0813404-9A2A BRPI0813404A2 (pt) 2007-06-22 2008-06-12 Derivados de uréia e carbamato como inibidores de transcriptase reversa de não-nucleosídeo

Country Status (15)

Country Link
US (1) US7947709B2 (pt)
EP (1) EP2170836A1 (pt)
JP (1) JP2010530863A (pt)
KR (1) KR20100039348A (pt)
CN (1) CN101784529A (pt)
AR (1) AR067076A1 (pt)
AU (1) AU2008267895A1 (pt)
BR (1) BRPI0813404A2 (pt)
CA (1) CA2692182A1 (pt)
CL (1) CL2008001819A1 (pt)
IL (1) IL202737A0 (pt)
MX (1) MX2009013865A (pt)
PE (1) PE20090419A1 (pt)
TW (1) TW200911804A (pt)
WO (1) WO2009000663A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008145562A1 (en) * 2007-05-30 2008-12-04 F. Hoffmann-La Roche Ag Non-nucleoside reverse transcriptase inhibitors

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0016787D0 (en) 2000-07-07 2000-08-30 Pfizer Ltd Compounds useful in therapy
EP1377556B1 (en) 2001-04-10 2007-04-04 Pfizer Limited Pyrazole derivatives for treating hiv
GB0113524D0 (en) 2001-06-04 2001-07-25 Hoffmann La Roche Pyrazole derivatives
JP2006504803A (ja) 2002-09-26 2006-02-09 ファイザー・インク ピラゾール誘導体
BR0314759A (pt) 2002-09-26 2005-07-26 Pfizer Derivados de pirazol
GB0223232D0 (en) 2002-10-07 2002-11-13 Pfizer Ltd Chemical compounds
CN100469769C (zh) 2003-03-24 2009-03-18 弗·哈夫曼-拉罗切有限公司 作为逆转录酶抑制剂的苄基-哒嗪酮
TW200505441A (en) 2003-03-24 2005-02-16 Hoffmann La Roche Non-nucleoside reverse transcriptase inhibitorsⅠ
CA2559552A1 (en) 2004-03-23 2005-09-29 F. Hoffmann-La Roche Ag Benzyl-pyridazinone derivatives as non-nucleoside reverse transcriptase inhibitors
US7625949B2 (en) 2004-04-23 2009-12-01 Roche Palo Alto Llc Methods for treating retroviral infections
US7166738B2 (en) 2004-04-23 2007-01-23 Roche Palo Alto Llc Non-nucleoside reverse transcriptase inhibitors
JP4675959B2 (ja) 2004-07-27 2011-04-27 エフ.ホフマン−ラ ロシュ アーゲー 非ヌクレオシド逆転写酵素阻害剤としてのベンジルトリアゾロン化合物
SE0401971D0 (sv) * 2004-08-02 2004-08-02 Astrazeneca Ab Piperidne derivatives
WO2006034583A1 (en) 2004-09-30 2006-04-06 Boehringer Ingelheim International Gmbh & Co Kg Alkynyl based dervatives of benzophenone as non-nucleoside reverse transcriptase inhibitors
EP1831157A2 (en) 2004-12-22 2007-09-12 Pfizer Limited Nonnucleoside inhibitors of hiv-1 reverse transcriptase
CA2600759A1 (en) 2005-03-24 2006-09-28 F. Hoffmann-La Roche Ag 1,2,4-triazole-5-one compounds as heterocyclic reverse transcriptase inhibitors
AR057455A1 (es) * 2005-07-22 2007-12-05 Merck & Co Inc Inhibidores de la transcriptasa reversa de vih y composicion farmaceutica
JP2009510013A (ja) 2005-09-30 2009-03-12 エフ.ホフマン−ラ ロシュ アーゲー Nnrt阻害剤
ES2320042T3 (es) 2005-10-19 2009-05-18 F. Hoffmann-La Roche Ag Inhibidores de transcriptasa reversa con nucleosidos de n-fenil fenilacetamida.
EP1940781A1 (en) 2005-10-19 2008-07-09 F.Hoffmann-La Roche Ag Phenyl-acetamide nnrt inhibitors
CL2007002105A1 (es) * 2006-07-21 2008-02-22 Hoffmann La Roche Compuestos derivados de 2-[3-(3-cianofenoxi)(fenoxi o fenilsulfanil)]-n-fenil acetamida, inhibidores de la transcriptasa inversa del vih; procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar u

Also Published As

Publication number Publication date
IL202737A0 (en) 2010-06-30
US20090012034A1 (en) 2009-01-08
TW200911804A (en) 2009-03-16
CN101784529A (zh) 2010-07-21
EP2170836A1 (en) 2010-04-07
JP2010530863A (ja) 2010-09-16
CL2008001819A1 (es) 2009-05-22
AR067076A1 (es) 2009-09-30
CA2692182A1 (en) 2008-12-31
US7947709B2 (en) 2011-05-24
MX2009013865A (es) 2010-01-27
PE20090419A1 (es) 2009-04-18
AU2008267895A1 (en) 2008-12-31
KR20100039348A (ko) 2010-04-15
WO2009000663A1 (en) 2008-12-31

Similar Documents

Publication Publication Date Title
ATE448196T1 (de) Inhibitoren der nicht-nukleosid-inhibitoren der reversen transkriptase
BRPI0813269A2 (pt) Inibidores de hiv transcriptase reversa
BRPI0715193A2 (pt) inibidores nço-nucleosÍdicos da transcriptase reversa
DK2046791T3 (da) Ureaderivater af tropan, fremstilling deraf og terepeutisk anvendelse deraf
NO20080746L (no) Urea-glukokinase-aktivatører
CR20130360A (es) Compuesto heterocíclico y su uso
FI20095678A0 (fi) Ureasubstituoituja sulfoniamidijohdannaisia
DK2144889T3 (da) Quinazolin-oxim derivater som HSP90 inhibitorer
IL199103A0 (en) Non-nucleoside reverse transcriptase inhibitors
BRPI0818003A2 (pt) inibidores de csf-1r, composições e métodos de uso
IL205386A0 (en) Non - nucleoside reverse transcriptase inhibitors
FI20086253A0 (fi) Sieniendoglukanaasit, niiden valmistus ja käyttö
DK2344486T3 (da) Alkylthiazolcarbamatderivater, fremstilling deraf og anvendelse deraf som hæmmere af enzymet FAAH
FI20086250A0 (fi) Sieniendoglukanaasit, niiden valmistus ja käyttö
DK1854789T3 (da) Quinazolinderivat med tyrosin-kinase inhibitorisk aktivitet
CR10879A (es) Cyclized derivatives as eg-5 inhibitors
EP2076492A4 (en) NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS
BRPI0812159A2 (pt) inibidores de csf-1r, composições e métodos de uso
ATE533761T1 (de) Imidazolidinonderivate
DK1869020T3 (da) Heteroarylureaderivater egnet til inhibering af CHK1
JP2009543766A5 (ja) mPGEs−1阻害剤としての2−アリールインドール誘導体
BRPI0913349A2 (pt) derivados de ureia e sulfamida macrocíclicos como inibidores de tafia
BRPI0810496A2 (pt) inibidores de transcriptase reversa de não-nucleosídeo
BRPI0714509A2 (pt) Inibidores de transcriptase reversa de não-nucleosídeo.
BRPI0813404A2 (pt) Derivados de uréia e carbamato como inibidores de transcriptase reversa de não-nucleosídeo

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]